BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-3 out of 3 found
  Current Search:  renvela: 3     

HTML
100%
Genzyme earnings battered by manufacturing problems
Genzyme Corps fourth quarter profits have been savaged as a result of the supply problems its products have suffered, notably the Gaucher disease drug Cerezyme.

Net income fell 73% to $23.2 million, reflecting the aftermath since June when the company's...

Pharma Times:  Feb 19 2010 1:30AM
Matching: renvela
Find similar documents
HTML
100%
Dialysis patients have new option
Genzyme Corp.

today announced the U.S.

launch of Renvela (sevelamer carbonate) for oral suspension, a powder dosing option for the control of serum phosphorus in patients with chronic kidney disease on dialysis.

Renvela is the only phosphate...

Knoxville Journal:  Feb 16 2010 7:24AM
Matching: renvela
Find similar documents
HTML
100%
Three Nephrology TreatmentTrends Publications from BioTrends Provide a Comprehensive View of Bone and Mineral
EXTON, Pa., Jan.

7 /PRNewswire/ -- BioTrends Research Group, Inc.

recently released its TreatmentTrends: US Nephrology, EU Nephrology, and Canadian Nephrology publications.

Each syndicated report offers comprehensive insight into the management of bone...

PR Newswire:  Jan 7 2010 10:29PM
Matching: renvela
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.